Zhu, Y.; Chen, Z.; Kim, S.N.; Gan, C.; Ryl, T.; Lesjak, M.S.; Rodemerk, J.; Zhong, R.D.; Wrede, K.; Dammann, P.;
et al. Characterization of Temozolomide Resistance Using a Novel Acquired Resistance Model in Glioblastoma Cell Lines. Cancers 2022, 14, 2211.
https://doi.org/10.3390/cancers14092211
AMA Style
Zhu Y, Chen Z, Kim SN, Gan C, Ryl T, Lesjak MS, Rodemerk J, Zhong RD, Wrede K, Dammann P,
et al. Characterization of Temozolomide Resistance Using a Novel Acquired Resistance Model in Glioblastoma Cell Lines. Cancers. 2022; 14(9):2211.
https://doi.org/10.3390/cancers14092211
Chicago/Turabian Style
Zhu, Yuan, Zhen Chen, Su Na Kim, Chao Gan, Tatsiana Ryl, Michaela Silvia Lesjak, Jan Rodemerk, Rong De Zhong, Karsten Wrede, Philipp Dammann,
and et al. 2022. "Characterization of Temozolomide Resistance Using a Novel Acquired Resistance Model in Glioblastoma Cell Lines" Cancers 14, no. 9: 2211.
https://doi.org/10.3390/cancers14092211
APA Style
Zhu, Y., Chen, Z., Kim, S. N., Gan, C., Ryl, T., Lesjak, M. S., Rodemerk, J., Zhong, R. D., Wrede, K., Dammann, P., & Sure, U.
(2022). Characterization of Temozolomide Resistance Using a Novel Acquired Resistance Model in Glioblastoma Cell Lines. Cancers, 14(9), 2211.
https://doi.org/10.3390/cancers14092211